Ground-breaking study may lead to accelerated sales pipeline for Nanosonics Canaccord Genuity Stockbroker
QRXPharma just saw its market cap shrink 75% from $120mil to $30mil on the FDA saying 'no', as Matthijs smith warned Livewire yesterday: There is unlikely to... Livewire Equities Livewire
